Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00110864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the safety and efficacy of PN2034 in insulin-dependent type 2 diabetics as measured by the change in average daily insulin dose from baseline to week 12. The effects of PN2034 on HbA1c, fasting plasma glucose (FPG), and lipid levels will also be measured.
Study identification
- NCT ID
- NCT00110864
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Apr 2007 (Actual)
- Last update posted
- Aug 23, 2007
2005 – 2007
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Internal Medicine Associates | Waterbury | Connecticut | 06708 | — |
| Center for Diabetes and Endocrine Care | Hollywood | Florida | 33021 | — |
| Genesis Research International | Longwood | Florida | 32779 | — |
| Baptist Diabetes Associates | Miami | Florida | 33156 | — |
| Andres Patron, DO PA | Pembroke Pines | Florida | 33028 | — |
| CLIRECO,Inc. | Tamarac | Florida | 33321 | — |
| Endocrine Clinical Research | Winter Park | Florida | 32789 | — |
| PRN of Kansas | Wichita | Kansas | 67203 | — |
| Medical Research Associates of Charlotte | Charlotte | North Carolina | 28211 | — |
| Neem Research Group of Charlotte | Charlotte | North Carolina | 28262 | — |
| Unifour Medical Research Associates | Hickory | North Carolina | 28601 | — |
| Neem Research Group of Raleigh | Raleigh | North Carolina | 27609 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| COR Clinical Research, LLC | Oklahoma City | Oklahoma | 73103 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Camp Hill Clinical Research Center | Camp Hill | Pennsylvania | 17011 | — |
| Neem Research Group | Columbia | South Carolina | 29201 | — |
| Oaks Medical Center | Spring | Texas | 77386 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00110864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2007 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00110864 live on ClinicalTrials.gov.